Your session is about to expire
← Back to Search
Other
Diet for Respiratory Disease
N/A
Waitlist Available
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinical diagnosis of AERD
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks and 12 weeks
Awards & highlights
Study Summary
The purpose of this study is to determine whether a low salicylate diet will improve the quality of life of patients with Aspirin Exacerbated Respiratory Disease (AERD).
Eligible Conditions
- Respiratory Disease
- Samter's Triad
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks and 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks and 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in SNOT-22 scores from Baseline
Secondary outcome measures
Change in Lund-Kennedy Endoscopic Score from Baseline
Side effects data
From 2018 Phase 4 trial • 2681 Patients • NCT015899784%
ANGINA PECTORIS
3%
ANGINA UNSTABLE
3%
NON-CARDIAC CHEST PAIN
2%
CORONARY ARTERY DISEASE
2%
CARDIAC FAILURE CONGESTIVE
1%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1%
PNEUMONIA
1%
ACUTE MYOCARDIAL INFARCTION
1%
ATRIAL FIBRILLATION
1%
CORONARY ARTERY DISSECTION
1%
CORONARY ARTERY THROMBOSIS
1%
DYSPNOEA
1%
GASTROINTESTINAL HAEMORRHAGE
1%
SYNCOPE
1%
MYOCARDIAL INFARCTION
100%
80%
60%
40%
20%
0%
Study treatment Arm
PROMUS Element
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: DietExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low salicylate diet
2013
N/A
~10
Find a Location
Who is running the clinical trial?
Hamilton Health Sciences CorporationLead Sponsor
368 Previous Clinical Trials
300,921 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger